sarkosyl has been researched along with Disease Exacerbation in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bohrmann, B; Collin, L; Göpfert, U; Grüninger, F; Oroszlan-Szovik, K; Ozmen, L | 1 |
| Iqbal, K; Korenova, M; Kovacech, B; Novak, M; Zilka, N | 1 |
| DeTure, M; Dickson, DW; Hutton, M; Lewis, J; McGowan, E; Sahara, N; Yen, SH | 1 |
3 other study(ies) available for sarkosyl and Disease Exacerbation
| Article | Year |
|---|---|
Neuronal uptake of tau/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Antibodies; Antibodies, Monoclonal; Blotting, Western; CA1 Region, Hippocampal; Disease Models, Animal; Disease Progression; Fluorescent Antibody Technique; Humans; Image Processing, Computer-Assisted; Lysosomes; Membrane Microdomains; Mice; Mice, Transgenic; Phosphorylation; Sarcosine; tau Proteins | 2014 |
CSF phospho-tau correlates with behavioural decline and brain insoluble phospho-tau levels in a rat model of tauopathy.
Topics: Animals; Brain; Detergents; Disease Models, Animal; Disease Progression; Humans; Longitudinal Studies; Phosphorylation; Rats; Rats, Transgenic; Sarcosine; Severity of Illness Index; tau Proteins; Tauopathies | 2010 |
Assembly of tau in transgenic animals expressing P301L tau: alteration of phosphorylation and solubility.
Topics: Age Factors; Amino Acid Substitution; Animals; Binding Sites; Brain; Brain Chemistry; Detergents; Disease Models, Animal; Disease Progression; Electrophoresis, Polyacrylamide Gel; Female; Humans; Macromolecular Substances; Male; Mice; Mice, Transgenic; Mutation; Phosphorylation; Sarcosine; Sex Factors; Solubility; tau Proteins; Tauopathies | 2002 |